AI's Impact in Health

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The potential of AI in health excites mainly due to the advancements in patient navigation tools that can provide personalized, high-quality care at a lower cost by leveraging large data sets. This can address the current inefficiencies in the healthcare system. Additionally, AI is revolutionizing drug discovery by accurately predicting molecular composition, protein fold, and function of large molecules, leading to the development of personalized medications.

This week, we’re super excited to chat with Brian Anderson, co-founder of CHAI, Coalition for Health AI, and Chief Digital Health Physician at MITRE.

CHAI is a community of academic health systems, organizations, and expert practitioners of artificial intelligence and data science. Brian leads research and development efforts across major strategic initiatives in digital health, partnering with the US government and private sector companies.

Prior to joining MITRE, Anderson led the Informatics and Network Medicine Division at athenahealth, where he launched a new model of clinical decision support leveraging artificial intelligence. He has also served on several national health information technology committees in partnership with the Office of the National Coordinator (ONC). On top of all that, Brian is also a Harvard Medical School Associate Professor of Biomedical Informatics and senior advisor for ARPA-H in Clinical Trial Innovation. Anderson completed his clinical training at Massachusetts General Hospital and completed his B.A. and M.D. degrees at Harvard College and Harvard Medical School.

In this episode, we talk about Brian’s career journey from clinical practice to digital health, CHAI’s efforts to establish AI process standards for healthcare, the concept of a federated network of assurance labs, and advice for the health AI innovation community.